Allergic rhinitis is an immunologically mediated disease that occurs frequently worldwide and is caused by a type I hypersensitivity reaction (IgE-mediated) to allergenic substances. The clinical symptoms mainly include rhinorrhea (runny nose), sneezing, nasal obstruction (blocked nose), nasal itching and ocular discomfort (red, itchy, watery eyes). Although these symptoms are not usually life-threatening, the quality of life of those affected can be significantly impaired. Many patients also suffer from sleep problems, fatigue and difficulty concentrating, which has a negative impact on their professional performance and social life [1].
You May Also Like
- Prostate cancer
Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management
- Pneumococcal conjugate vaccine (PCV)
Best possible serotype coverage in the respective age group
- Psoriasis: intervening in the inflammatory cascade
Advantages of early biologic therapy and oral peptide as a beacon of hope
- AI-supported imaging and new biomarkers
CHD diagnostics update
- Bipolar disorder, anxiety disorder, depression
Lurasidone as monotherapy for bipolar I depression with anxiety symptoms
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Low-grade pediatric gliomas